A-ha’s Morten Harket revealed Wednesday that he has been diagnosed with Parkinson’s disease, which could impact the “Take on Me” singer’s powerful voice and “creative future.” Harket ...

HHS plans to fold the CDC's chronic disease center into the new Administration for a Healthy America. Experts fear for coordination with local health departments, among other things.

For Scheuermann’s kyphosis, a disease for which we do not know the cause, the likelihood of progression is often based on the history of progression through growth. For example, if a healthy, fit ...

People with an autism diagnosis are at a higher risk of developing Parkinson's disease early in life, a large-scale study from Karolinska Institutet published in JAMA Neurology reports. The ...

More information: Almudena Chicote‐González et al, Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an ...

Whipple’s disease is a rare but serious systemic infection caused by the bacterium Tropheryma whipplei. It’s found in the environment and even in asymptomatic carriers but targets middle-aged ...

This genetic profile accounts for only 2% of the general population, but 15% of people with Alzheimer’s disease. Improving diagnosis and tempering expectations It’s estimated more than 400,000 ...

Alan Alda continues acting despite Parkinson’s disease, recently appearing in Tina Fey’s adaptation of his 1981 film, ‘The Four Seasons’ on Netflix.

Alzheimer’s disease is the most common form of dementia. Nadino/Shutterstock. Among people with Alzheimer’s disease, 0.44% had a previous HSV-1 diagnosis, compared to 0.24% of controls.

The beloved 'M*A*S*H' star was diagnosed with Parkinson's in 2015 Dia Dipasupil/Getty Alan Alda is sharing a health update on how he manages his Parkinson's disease, which he was first diagnosed ...

Brain health advocates share tips for detecting Alzheimer’s Disease early, including tests and early signs. Plus, prevention tips to tweak your routine.

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.